1-153340507-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020393.4(PGLYRP4):c.698C>T(p.Ala233Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000385 in 1,614,126 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGLYRP4 | NM_020393.4 | c.698C>T | p.Ala233Val | missense_variant | 7/9 | ENST00000359650.10 | NP_065126.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGLYRP4 | ENST00000359650.10 | c.698C>T | p.Ala233Val | missense_variant | 7/9 | 1 | NM_020393.4 | ENSP00000352672.5 | ||
PGLYRP4 | ENST00000368739.3 | c.686C>T | p.Ala229Val | missense_variant | 7/9 | 5 | ENSP00000357728.3 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000549 AC: 138AN: 251234Hom.: 1 AF XY: 0.000486 AC XY: 66AN XY: 135772
GnomAD4 exome AF: 0.000397 AC: 581AN: 1461868Hom.: 1 Cov.: 31 AF XY: 0.000392 AC XY: 285AN XY: 727232
GnomAD4 genome AF: 0.000269 AC: 41AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.698C>T (p.A233V) alteration is located in exon 7 (coding exon 6) of the PGLYRP4 gene. This alteration results from a C to T substitution at nucleotide position 698, causing the alanine (A) at amino acid position 233 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at